Key facts
- It has raised $1.4M; the latest was Later Stage VC ($770K) in Mar 2025.
- Notable investors include Creative Destruction Lab, New York Angels, Scale Good Fund, Front Row Ventures, Allied Venture Partners — 17 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 17 names
- ·Watchlist + deal alerts for Retinalogik
- ·The full record, as it builds
Funding rounds
No funding rounds for Retinalogik are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Retinalogik
Developer and manufacturer of AI/VR-enabled visual screening devices designed to prevent vision loss by providing smarter access to quality eye care for everyone. The company's eye technology helps users check their vision on intelligent and portable devices, enabling customers to have clear vision at affordable prices and detect conditions early.
- Sector
- Healthcare
- HQ
- Calgary, Canada
- Founded
- 2019
- Employees
- 11
- Website
- retinalogik.com/
- Ownership
- Privately Held (backing)
Retinalogik doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Retinalogik shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Retinalogik in its N-PORT filings yet. We sweep new filings monthly.